Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Inhibitors >  Sitagliptin phosphate monohydrate

Sitagliptin phosphate monohydrate

Basic information Safety Supplier Related

Sitagliptin phosphate monohydrate Basic information

Product Name:
Sitagliptin phosphate monohydrate
Synonyms:
  • Sitagliptin monohydrate
  • Sitagliptin Phosphate.H2O
  • Sitagliptin Monophosphate Monohydrate
  • (R)-3-AMino-1-(3-(trifluoroMethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one phosphate hydrate
  • Sitaglipin Phosphate Monohydrate
  • (R)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one phosphate monohydrate
  • (R)-3-Amino-1-(3-(trifluor
  • Sitagliptin posphate monohydrate
CAS:
654671-77-9
MF:
C16H18F6N5O5P
MW:
505.31
EINECS:
682-492-2
Product Categories:
  • Inhibitors
  • Inhibitor
  • API
  • APIs
  • 654671-77-9
Mol File:
654671-77-9.mol
More
Less

Sitagliptin phosphate monohydrate Chemical Properties

Flash point:
274.3℃
storage temp. 
2-8°C
solubility 
≥23.8 mg/mL in DMSO; insoluble in EtOH; ≥30.6 mg/mL in H2O with ultrasonic
form 
solid
CAS DataBase Reference
654671-77-9(CAS DataBase Reference)
More
Less

Safety Information

Risk Statements 
28-38-41-48-62-63
Safety Statements 
24/25-26-28-36/37/39
HS Code 
29335990
More
Less

Sitagliptin phosphate monohydrate Usage And Synthesis

Chemical Properties

white crystalline

Uses

antimuscarinic

Uses

Sitagliptin Phosphate Monohydrate is a dipeptidyl peptidase-IV (DPPIV) inhibitor.

Biological Activity

sitagliptin phosphate monohydrate is the phosphate salt of its active component, sitagliptin, with one molecule of water. sitagliptin is a potent inhibitor of dipeptidyl peptidase 4 (dpp-4), an enzyme catalyzing the cleavage of peptides with an n-terminal alanine or proline amino acid residue, that selectively inhibits dpp-4 with 50% inhibition concentration ic50 value of 18 nm and shows no affinity towards other ddp enzymes (such as ddp-8 and ddp-9). the inhibition of dpp4 by sitagliptin has been found to be mediated by increasing levels of two dpp-4 substrates, including glucagon-like peptide-1 (glp-1) and gastric inhibitory polypeptide (gip). sitagliptin is currently being investigated in the treatment of type ii diabetes.gallwitz b. review of sitagliptin phosphate: a novel treatment for type 2 diabetes. vasc health risk manag. 2007;3(2):203-10.

target

DPP-4

Sitagliptin phosphate monohydrateSupplier

Hefei HomeSunshine Pharmaceutical Technology Co., Ltd. Gold
Tel
0551-65523315 17705606359
Email
errol@homesunshinepharma.com
Changzhou Kangte Pharmtech Co.,Ltd Gold
Tel
0519-82813797 18994752886
Email
czkangte@hotmail.com
Ningbo Zhenlei Chemical Co.,ltd. Gold
Tel
0576-057688203603 13958565781
Email
shuang.lin@zhenleichem.com
AnHui HaiKang Pharmaceutical Co., Ltd. Gold
Tel
0556-5800026 17709662922
Email
melrose@worldpharma.cn
Beijing Huikang Boyuan Chemical Tech Co., Ltd Gold
Tel
010-68862197 13810598707
Email
sales@huikangchem.com